TISSUE TESTING TECHNOLOGIES LLC
North Charleston, SC · Medtech · Acquired
Ice-free cryopreservation system using vitrification and radio frequency nanowarming to preserve meniscal tissue viability for transplantation
- Grants
- $9.6M
- 28 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $1.4M
- 4 awards · Defense
- #273 of 4531 in medtech
- Patents
- 16
- 2 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Nanowarming technology for effective rewarming of vitrified tissues and organs | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Nanowarming technology for effective rewarming of vitrified tissues and organs | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Immunogenicity of wild-type pig tissues after ice-free cryopreservation in genetically engineered recipients | $224,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Immunogenicity of wild-type pig tissues after ice-free cryopreservation in genetically engineered recipients | $224,999 | |
| Federal grant | Department of Health and Human Services · Phase II · Cryopreservation of Engineered Tissue Equivalents | $485,382 | |
| Federal contract· 1 of 2 same day | Department of Defense · Igf::ot::igf. Dhp Phase I Proposal H151-013-0162 Entitled "avoiding The Ice Cryolesion In Tissue Cryopreservation With Ice Modulators." | $149,999 | |
| Federal contract· 2 of 2 same day | Department of Defense · Igf::ot::igf. Dhp Phase I Proposal H151-014-0042 Entitled "rapid Rewarming Reduction Of Cryoprotectant Toxicity And Concentration Employing Magnetic Nanoparticles." | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Stasis technology for storage and transport of natural and engineered tissues | $225,861 | |
| Federal contract | Department of Defense · Igf::ot::igf. Dhp Phase II Proposal H2-0159 Entitled, "optimal Rewarming Solutions For Cryopreserved Tissue Systems: Rapid Rewarming Reduction Of Cryoprotectant Toxicity And Concentration Employing Magnetic Nanoparticles." | $938,442 | |
| Federal contract | Department of Defense · Igf::ot::igf Army SBIR Phase I Proposal A161-049-0509, Tissue Testing Technologies | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Ice Free Vitrification and nanowarming of large cartilage samples for transplantation | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase I · DMSO-free Cryopreservation of Bone Marrow-derived Stem Cells | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Construction and testing of a rabbit cornea-equivalent for evaluation of chemical injury in vitro | $224,985 | |
| Federal grant | Department of Health and Human Services · Phase I · Construction and testing of a rabbit cornea-equivalent for evaluation of chemical injury in vitro | $224,985 | |
| Federal grant | Department of Health and Human Services · Phase I · Automation of bioengineered epithelial construct cryopreservation | $149,977 | |
| Federal grant | Department of Health and Human Services · Phase II · Ice-free vitrification and nano warming technology for banking of cardiovascular structures. | $365,069 | |
| Federal grant | Department of Health and Human Services · Phase II · Ice-free vitrification and nanowarming of large osteochondral grafts for transplantation | $838,363 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a High Throughput Method for Vitrification | $275,302 | |
| Federal grant | Department of Health and Human Services · Phase I · Ice-free cryopreservation of whole pediatric testes for autologous banking and replantation. | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Ice-free vitrification and nanowarming of large osteochondral grafts for transplantation | $826,749 | |
| Federal grant | Department of Health and Human Services · Phase I · Feasibility of expanding ischemia time for hearts destined for transplantation | $386,026 | |
| Federal grant | Department of Health and Human Services · Phase I · Extended limb preservation employing an optimization strategy for stabilization. | $339,546 | |
| Federal grant | Department of Health and Human Services · Phase II · Ice-free vitrification and nano warming technology for banking of cardiovascular structures. | $837,815 | |
| Federal grant | Department of Health and Human Services · Phase II · Ice-free vitrification and nano warming technology for banking of cardiovascular structures. | $12,392 | |
| Federal grant | Department of Health and Human Services · Phase II · Ice-free vitrification and nano warming technology for banking of cardiovascular structures. | $706,149 | |
| Federal grant | Department of Health and Human Services · Phase II · Ice-free vitrification and nano warming technology for banking of cardiovascular structures. | $124,317 | |
| Federal grant | Department of Health and Human Services · Phase II · Mechanistic approach to optimization of a kidney preservation solution | $385,522 | |
| Federal grant | Department of Health and Human Services · Phase I · Mechanistic approach to optimization of a kidney preservation solution | $385,522 | |
| Federal grant | Department of Health and Human Services · Phase I · Evaluation of growth potential of ice-free vitrified heart valves in a pediatric porcine model. | $452,184 | |
| Federal grant | Department of Health and Human Services · Phase I · Evaluation of growth potential of ice-free vitrified heart valves in a pediatric porcine model. | $158,788 | |
| Federal grant | Department of Health and Human Services · Phase I · Ice-free vitrification and nanowarming of meniscal grafts for transplantation | $302,037 | |
| Federal grant | Department of Health and Human Services · Phase I · Ice-free vitrification and nanowarming of meniscal grafts for transplantation | $302,037 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 270 | Biotex, Inc. | $1.4M | — |
| 271 | ADVANCED SILICON GROUP, INC. | $1.4M | $1.0M |
| 272 | Olifant Medical, Inc. | $1.4M | — |
| 273 | TISSUE TESTING TECHNOLOGIES LLC | $1.4M | — |
| 274 | AutoGenomics, Inc. | $1.4M | $71M |
| 275 | YOU TUNE HEARING PROTECTION LLC | $1.4M | — |
| 276 | Turner Innovations L.C. | $1.3M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Ice-free Preservation Of Large Volume Tissue Samples For Viable, Functional Tissue Bankinggranted
- Enhancement Of Cell Cryopreservation With Glycolipidsgranted
- Preservation Methods Using Trehalose With Other Cryoprotectants Being Absent From The Cryopreservation Protocolapplication
- Cassette For Preservation Of Natural And Bioengineered Tissuesapplication
- Preservation Of Natural And Bionengineered Tissues And Methods Of Storing And Transportapplication
- Minimizing Immunogenicity Of Decellularized Tissuesapplication
- Preservation Methods Using Trehalose With Other Cryoprotectants Being Absent From The Cryopreservation Protocolapplication
- Ice-free Vitrification And Nano-warming Of Large Tissue Samplesapplication
- Minimizing Immunogenicity Of Decellularized Tissuesapplication
- Ice-free Vitrification And Nano-warming Of Large Tissue Samplesapplication
- Ice-free Preservation Of Large Volume Tissue Samples For Viable, Functional Tissue Bankingapplication
- Enhancement Of Cell Cryopreservation With Glycolipidsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.